Ryan D. Lake
2020 - Recro Pharma
In 2020, Ryan D. Lake earned a total compensation of $2.2M as Chief Financial Officer at Recro Pharma, a 43% increase compared to previous year.
Compensation breakdown
| Bonus | $48,000 |
|---|---|
| Non-Equity Incentive Plan | $107,640 |
| Option Awards | $744,327 |
| Salary | $198,985 |
| Stock Awards | $1,058,040 |
| Other | $24,673 |
| Total | $2,181,665 |
Lake received $1.1M in stock awards, accounting for 48% of the total pay in 2020.
Lake also received $48K in bonus, $107.6K in non-equity incentive plan, $744.3K in option awards, $199K in salary and $24.7K in other compensation.
Rankings
In 2020, Ryan D. Lake's compensation ranked 5,133rd out of 13,090 executives tracked by ExecPay. In other words, Lake earned more than 60.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,133 out of 13,090 | 61st |
Division Manufacturing | 2,100 out of 5,620 | 63rd |
Major group Chemicals And Allied Products | 838 out of 2,253 | 63rd |
Industry group Drugs | 724 out of 1,953 | 63rd |
Industry Pharmaceutical Preparations | 545 out of 1,458 | 63rd |
Source: SEC filing on March 25, 2021.
Lake's colleagues
We found two more compensation records of executives who worked with Ryan D. Lake at Recro Pharma in 2020.
News
Recro Pharma CEO J Enloe's 2022 pay jumps 107% to $2.3M
April 6, 2023
Recro Pharma CFO Ryan Lake's 2021 pay jumps 622% to $2.3M
April 1, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020